DEVELOPMENT OF A METHODOLOGY FOR THE PRODUCTION OF SPECIFIC ALLOANTIGEN- REACTIVE HUMAN TREGS
therapy has demonstrated efficacy in maintaining graft function. However, optimal Treg immunotherapy should employ alloantigen-?reactive rather than polyclonally-?reactive Tregs to ensure bothsafety and enhanced…

